抗幽门螺旋杆菌感染治疗特发性血小板减少性紫癜疗效研究被引量：9

Clinical Research of Eradication of Helicobacter pylori in Patients with Idiopathic Thrombocytopenic Purpura

下载PDF

导出

摘要目的研究单独抗幽门螺旋杆菌（Hp）感染对特发性血小板减少性紫癜患者的血小板恢复情况.方法选择35例特发性血小板减少性紫癜伴Hp感染,并且血小板大于30×109/L的患者;单独抗Hp感染,以根除Hp感染,观察治疗前后血小板变化,考察Hp根除后,特发性血小板减少性紫癜患者的血小板变化情况.结果 35例患者Hp根治率达到82.9％（30/35）,需要1～2个疗程达到Hp阴性,治疗前血小板中位数37×109/L;Hp转阴后血小板中位数62×109/L; 30例Hp根治后,其中4例（13.3％）达到良好反应,17例（56.7％）达到部分反应.结论特发性血小板减少性紫癜合并Hp感染,Hp根除后,血小板减少有不同程度改善,甚至部分达到良好反应,这种治疗方法值得推广. Objective To investigate the effect of Helicobacter pylori eradication therapy on the recovery of platelet in patients with idiopathic thrombocytopenic purpura.Methods We studied the effect of H.pylori eradication in 35 H.pylori-positive patients with ITP,and platelet more than 30 × 109/L,by comparing the change of the patient＇s platelet levels before and after treatment.Results By 1 ～ 2 courses of eradicating Helicobacter pylori,the eradication therapy was successful in 35 patients （82.9％）.The median value of patient＇s platelet was 37 × 109/L,62 × 109/L before the treatment and after Hp-negative,respectively.Among of 30 Hp-negative patients,4 patients showed good response,and 17 patients showed partial response.Conclusion After Helicobacter pylori eradication in H.pylori-positive ITP patients,they showed different improvement in platelet count,even good response and partial response,so we advocate the treatment.

作者詹其林吴福红丁美琪

机构地区上海市第六人民医院金山分院血液科安徽省六安市人民医院血液科

出处《医学研究杂志》 2014年第4期122-124,共3页 Journal of Medical Research

关键词幽门螺旋杆菌感染治疗特发性血小板减少性紫癜 Helicobacter pylori Infection Therapy Idiopathic thrombocytopenic purpura

分类号 R552 [医药卫生—血液循环系统疾病]

引文网络
相关文献

参考文献16

1Graham DY.Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer:a model[J].Gastroenterology,1997,113(6):1983-1991.
2Parsonnet J,Hansen S,Rodriguez L,et al.Helicobacter pylori infection and gastric carcinoma[J].N Engl J Med,1994,330 (18):1267-1271.
3Zentillin P,Savarino V,Garnero A,et al.Is Helicobacter pylori infection a risk factor or disease severity in rheumatoid arthritis?[J].Gastroenterology,1999,116 (2):503-504.
4De Luis DA,Valela C,de la Calle H,et al.Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis[J].J Clin Gastroenterol,1998,26 (4):259-263.
5Faria C,Zakout R,Araujo M.Helicobacter pylori and autoimmune diseases[J].Biomed Pharmacother,2013,67 (4):347-349.
6Gasbarrini A,Franceschi F,Tartaglione R,et al.Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori[J].Lancet,1998,352(9131):878.
7Emilia G,Luppi M,Morselli M,et al.Helicobaeter pylori infection and idiopathic thrombocytopenic purpura[J].Br J Haematol,2002,118(4):1198-1199.
8Veneri D,Franchini M,Gottardi M,et al.Efficacy of helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura[J].Haematologica,2002,87 (11):1177-1179.
9Kohda K,Kuga T,Kogawa K,et al.Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura[J].Br J Haematol,2002,118(2):584-5888.
10Michel M,Khellaf M,Desforges L,et al.Autoimmune thrombocytopenic purpura and helicobacter pylori infection[J].Arch Intern Med,2002,162(9):1033-1036.

二级参考文献47

1Rodeghiero F, Stasi R, Gemsheimer T et al. Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group [ J ]. Blood,2009; 113( 11 ) :2386-2393.
2Beardsley DS. ITP in the 21^st century[ J]. Hematology,2006; 1:402-407.
3Wu C L, Xu J C, Li F etal. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura[ J ]. Int J Lab Hematol, 2007 ; 29 (3) : 177-184.
4Zhang F, Chu X,Hou Met al. Cell-mediated lysis of autologous platelets in chronic diopathic thrombocytopenic purpura[J]. Eur J Haematol,.2006; 76: 427-431.
5Webster M L, Sayeh E, Crow Met al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GP Ⅱ b Ⅲ a versus GP I b antibodies[ J ]. Blood, 2006; 108 (3) :943-946.
6George J N,Woolf S H, Raskob G E et al. Idiopathic thrombocytopenic puiptwa: a practice guideline developed by explicit methods for the American Society of Hematology [ J ]. Blood, 1996; 88 ( 1 ) : 3-40.
7Fabris F, Scandellari R, Ruzzon E et al. Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpum[ J]. Blood, 2004; 103(12) :4562-4564.
8Cines D B, McMillan R. Management of adult idiopathic thrombocytopenic purpura[J]. Annu Rev Med,2005;56:425-d42.
9Provan D,Newland A,Bolton-Maggs Pet al. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[ J]. Br J Haematol,2003; 120(4) :574-596.
10Borst F, Keuning J J, van Hulsteijn H etal. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults[ J ]. Ann Hematol, 2004; 83 ( 12 ) : 764-768.